Skip to main content

Therapeutics Startups

Updated August 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,699 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,699
Total Funding
$1.3B
Avg Funding
$53.0M
Global Reach
8
countries

Top Cities for Therapeutics

White Plains
New York
San Carlos
Paris
Waltham
Tokyo

Recently Funded Companies

Export
White Plains, United States

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.

$7.1M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

New York, United States

MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.

$100.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

San Carlos, United States

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

$115.0M raised
Apr 2025

Founder Contacts

41,000+ verified contacts

Paris, France

Smart Immune is a biotech company that helps fight against cancer and infection by providing a thymus-empowered T-cell therapy platform.

$5.0M raised
Apr 2023

Founder Contacts

41,000+ verified contacts

Waltham, United States

Alloy Therapeutics is a biotechnology company that provides drug discovery services to support the development of therapeutic biologics.

$40.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Tokyo, Japan

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.

$8.2M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

Verismo Therapeutics is a biotechnology company that develops CAR T cell therapy for the treatment of solid tumors.

$28.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.

$300.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

San Carlos, United States

Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.

$90.0M raised
Apr 2025

Founder Contacts

41,000+ verified contacts

Chicago, United States

Oxalo Therapeutics creates drugs to treat rare kidney diseases and prevent recurring kidney stones.

$1000K raised
Apr 2022

Founder Contacts

41,000+ verified contacts

Sunrise, United States

Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.

$403.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Cleveland, United States

Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.

$700K raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.

$75.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Singapore, Singapore

Effective and Accessible Healthcare for Every Human

$2.0M raised
Apr 2025

Founder Contacts

41,000+ verified contacts

San Diego, United States

Neomorph develops protein degradation therapies targeting diseases not addressed by conventional treatments.

$100.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Eugene, United States

InVivo Biosystems specializes in genome editing and preclinical research for neurological, metabolic, and rare monogenic diseases.

Apr 2025

Founder Contacts

41,000+ verified contacts

Yachats, United States

NeuroPro Therapeutics is a pharmaceutical company that develops drugs to treat epilepsy and other neurological disorders.

$5.1M raised
Apr 2023

Founder Contacts

41,000+ verified contacts

New York, United States

Episteme Prognostics is a precision medicine company developing therapeutic biomarkers for pancreatic cancer.

$4.1M raised
Apr 2023

Founder Contacts

41,000+ verified contacts

Illkirch-graffenstaden, France

Odimma is a biotech company that focuses on precision medicine and cure for personalized cancer immunotherapy.

$2.0M raised
Apr 2023

Founder Contacts

41,000+ verified contacts

Zürich, Switzerland

Versantis is a pharmaceutical company developing medicine to revolutionize the care of patients.

$509K raised
Apr 2022

Founder Contacts

41,000+ verified contacts

Ponte Vedra Beach, United States

Cadrenal Therapeutics develops a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation.

$2.5M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Matsuyama-shi, Japan

OB is a biotechnology company committed to developing innovative scfv antibody based therapies for the treatment of patients with cancers.

Apr 2026

Founder Contacts

41,000+ verified contacts

Esch-sur-alzette, Luxembourg

Exobiosphere is a cutting-edge company operating at the intersection of space exploration and biotechnology.

$1.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Raspberry Circle is an app studio that creates simple & creative apps that help people live healthy lives.

$1.3M raised
Apr 2025

Founder Contacts

41,000+ verified contacts

Emeryville, United States

Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

$32.5M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Showing 651 to 675 of 1,699 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,699 therapeutics companies tracked in the VCBacked database.

Average Funding
$53.0M
Total Funding Tracked
$1.3B
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.New York
2 companies$104.1M
2.San Carlos
2 companies$205.0M
3.White Plains
1 companies$7.1M
4.Paris
1 companies$5.0M
5.Waltham
1 companies$40.0M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked